Rigosertib Completed Phase 3 Trials for Pancreatic Adenocarcinoma Metastatic Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01360853Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer